263 related articles for article (PubMed ID: 29720252)
21. IgG Fc sialylation is regulated during the germinal center reaction following immunization with different adjuvants.
Bartsch YC; Eschweiler S; Leliavski A; Lunding HB; Wagt S; Petry J; Lilienthal GM; Rahmöller J; de Haan N; Hölscher A; Erapaneedi R; Giannou AD; Aly L; Sato R; de Neef LA; Winkler A; Braumann D; Hobusch J; Kuhnigk K; Krémer V; Steinhaus M; Blanchard V; Gemoll T; Habermann JK; Collin M; Salinas G; Manz RA; Fukuyama H; Korn T; Waisman A; Yogev N; Huber S; Rabe B; Rose-John S; Busch H; Berberich-Siebelt F; Hölscher C; Wuhrer M; Ehlers M
J Allergy Clin Immunol; 2020 Sep; 146(3):652-666.e11. PubMed ID: 32445838
[TBL] [Abstract][Full Text] [Related]
22. Engineered Sialylation of Pathogenic Antibodies In Vivo Attenuates Autoimmune Disease.
Pagan JD; Kitaoka M; Anthony RM
Cell; 2018 Jan; 172(3):564-577.e13. PubMed ID: 29275858
[TBL] [Abstract][Full Text] [Related]
23. Up-regulation of alpha2,6 sialylation during myeloid maturation: a potential role in myeloid cell release from the bone marrow.
Le Marer N; Skacel PO
J Cell Physiol; 1999 Jun; 179(3):315-24. PubMed ID: 10228950
[TBL] [Abstract][Full Text] [Related]
24. Sialylated Autoantigen-Reactive IgG Antibodies Attenuate Disease Development in Autoimmune Mouse Models of Lupus Nephritis and Rheumatoid Arthritis.
Bartsch YC; Rahmöller J; Mertes MMM; Eiglmeier S; Lorenz FKM; Stoehr AD; Braumann D; Lorenz AK; Winkler A; Lilienthal GM; Petry J; Hobusch J; Steinhaus M; Hess C; Holecska V; Schoen CT; Oefner CM; Leliavski A; Blanchard V; Ehlers M
Front Immunol; 2018; 9():1183. PubMed ID: 29928274
[TBL] [Abstract][Full Text] [Related]
25. The Inhibitory Role of α2,6-Sialylation in Adipogenesis.
Kaburagi T; Kizuka Y; Kitazume S; Taniguchi N
J Biol Chem; 2017 Feb; 292(6):2278-2286. PubMed ID: 28031460
[TBL] [Abstract][Full Text] [Related]
26. Regulation of autoantibody activity by the IL-23-T
Pfeifle R; Rothe T; Ipseiz N; Scherer HU; Culemann S; Harre U; Ackermann JA; Seefried M; Kleyer A; Uderhardt S; Haugg B; Hueber AJ; Daum P; Heidkamp GF; Ge C; Böhm S; Lux A; Schuh W; Magorivska I; Nandakumar KS; Lönnblom E; Becker C; Dudziak D; Wuhrer M; Rombouts Y; Koeleman CA; Toes R; Winkler TH; Holmdahl R; Herrmann M; Blüml S; Nimmerjahn F; Schett G; Krönke G
Nat Immunol; 2017 Jan; 18(1):104-113. PubMed ID: 27820809
[TBL] [Abstract][Full Text] [Related]
27. Sialylation of human IgG-Fc carbohydrate by transfected rat alpha2,6-sialyltransferase.
Jassal R; Jenkins N; Charlwood J; Camilleri P; Jefferis R; Lund J
Biochem Biophys Res Commun; 2001 Aug; 286(2):243-9. PubMed ID: 11500028
[TBL] [Abstract][Full Text] [Related]
28. Suppression of rheumatoid arthritis B cells by XmAb5871, an anti-CD19 antibody that coengages B cell antigen receptor complex and Fcγ receptor IIb inhibitory receptor.
Chu SY; Yeter K; Kotha R; Pong E; Miranda Y; Phung S; Chen H; Lee SH; Leung I; Bonzon C; Desjarlais JR; Stohl W; Szymkowski DE
Arthritis Rheumatol; 2014 May; 66(5):1153-64. PubMed ID: 24782179
[TBL] [Abstract][Full Text] [Related]
29. Majority of alpha2,6-sialylated glycans in the adult mouse brain exist in O-glycans: SALSA-MS analysis for knockout mice of alpha2,6-sialyltransferase genes.
Ohmi Y; Nishikaze T; Kitaura Y; Ito T; Yamamoto S; Sugiyama F; Matsuyama M; Takahashi Y; Takeda A; Kawahara T; Okajima T; Furukawa K; Furukawa K
Glycobiology; 2021 Jun; 31(5):557-570. PubMed ID: 33242079
[TBL] [Abstract][Full Text] [Related]
30. alpha 2-6-Linked sialic acids on N-glycans modulate carcinoma differentiation in vivo.
Hedlund M; Ng E; Varki A; Varki NM
Cancer Res; 2008 Jan; 68(2):388-94. PubMed ID: 18199532
[TBL] [Abstract][Full Text] [Related]
31. Protein sialylation by sialyltransferase involves radiation resistance.
Lee M; Lee HJ; Bae S; Lee YS
Mol Cancer Res; 2008 Aug; 6(8):1316-25. PubMed ID: 18708363
[TBL] [Abstract][Full Text] [Related]
32. Chinese hamster ovary (CHO) host cell engineering to increase sialylation of recombinant therapeutic proteins by modulating sialyltransferase expression.
Lin N; Mascarenhas J; Sealover NR; George HJ; Brooks J; Kayser KJ; Gau B; Yasa I; Azadi P; Archer-Hartmann S
Biotechnol Prog; 2015; 31(2):334-46. PubMed ID: 25641927
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of sialylation on humanized IgG-like bispecific antibody by overexpression of α2,6-sialyltransferase derived from Chinese hamster ovary cells.
Onitsuka M; Kim WD; Ozaki H; Kawaguchi A; Honda K; Kajiura H; Fujiyama K; Asano R; Kumagai I; Ohtake H; Omasa T
Appl Microbiol Biotechnol; 2012 Apr; 94(1):69-80. PubMed ID: 22205442
[TBL] [Abstract][Full Text] [Related]
34. Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity.
Quast I; Keller CW; Maurer MA; Giddens JP; Tackenberg B; Wang LX; Münz C; Nimmerjahn F; Dalakas MC; Lünemann JD
J Clin Invest; 2015 Nov; 125(11):4160-70. PubMed ID: 26436649
[TBL] [Abstract][Full Text] [Related]
35. In vitro glycoengineering of IgG1 and its effect on Fc receptor binding and ADCC activity.
Thomann M; Schlothauer T; Dashivets T; Malik S; Avenal C; Bulau P; Rüger P; Reusch D
PLoS One; 2015; 10(8):e0134949. PubMed ID: 26266936
[TBL] [Abstract][Full Text] [Related]
36. Glycoengineering of therapeutic glycoproteins: in vitro galactosylation and sialylation of glycoproteins with terminal N-acetylglucosamine and galactose residues.
Raju TS; Briggs JB; Chamow SM; Winkler ME; Jones AJ
Biochemistry; 2001 Jul; 40(30):8868-76. PubMed ID: 11467948
[TBL] [Abstract][Full Text] [Related]
37. Mice deficient in the St3gal3 gene product α2,3 sialyltransferase (ST3Gal-III) exhibit enhanced allergic eosinophilic airway inflammation.
Kiwamoto T; Brummet ME; Wu F; Motari MG; Smith DF; Schnaar RL; Zhu Z; Bochner BS
J Allergy Clin Immunol; 2014 Jan; 133(1):240-7.e1-3. PubMed ID: 23830412
[TBL] [Abstract][Full Text] [Related]
38. ST6GAL1 inhibits metastasis of hepatocellular carcinoma via modulating sialylation of MCAM on cell surface.
Zou X; Lu J; Deng Y; Liu Q; Yan X; Cui Y; Xiao X; Fang M; Yang F; Sawaki H; Sato T; Tan B; Lu X; Feng B; Kuno A; Narimatsu H; Gao C; Zhang Y
Oncogene; 2023 Feb; 42(7):516-529. PubMed ID: 36528750
[TBL] [Abstract][Full Text] [Related]
39. Treatment response in Kawasaki disease is associated with sialylation levels of endogenous but not therapeutic intravenous immunoglobulin G.
Ogata S; Shimizu C; Franco A; Touma R; Kanegaye JT; Choudhury BP; Naidu NN; Kanda Y; Hoang LT; Hibberd ML; Tremoulet AH; Varki A; Burns JC
PLoS One; 2013; 8(12):e81448. PubMed ID: 24324693
[TBL] [Abstract][Full Text] [Related]
40. Enzymatic basis for N-glycan sialylation: structure of rat α2,6-sialyltransferase (ST6GAL1) reveals conserved and unique features for glycan sialylation.
Meng L; Forouhar F; Thieker D; Gao Z; Ramiah A; Moniz H; Xiang Y; Seetharaman J; Milaninia S; Su M; Bridger R; Veillon L; Azadi P; Kornhaber G; Wells L; Montelione GT; Woods RJ; Tong L; Moremen KW
J Biol Chem; 2013 Nov; 288(48):34680-98. PubMed ID: 24155237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
